High innate production of interleukin-10 and tumor necrosis factor-alpha contributes to susceptibility for non-paraneoplastic Lambert-Eaton myasthenic syndrome

J Neuroimmunol. 2003 Jul;140(1-2):194-7. doi: 10.1016/s0165-5728(03)00205-4.

Abstract

Non-paraneoplastic Lambert-Eaton myasthenic syndrome (LEMS) is an antibody-mediated autoimmune disorder, in which genetically determined interleukin-10 (Il-10) and tumor necrosis factor-alpha (TNF-alpha) could play a role in the susceptibility for the disease. Therefore, we analyzed the production of Il-10 and TNF-alpha after whole-blood stimulation in first-degree family members of patients with LEMS without malignancy, as a measure of innate production in the patients. Thirty-six first-degree family members of 10 patients and 80 healthy controls were studied. Both Il-10 (p=0.037) and TNF-alpha (p=0.0016) production were increased in the family members, but had no relation with the severity of LEMS or HLA-B8DR3 carriership. Our findings suggest that high innate production of Il-10 and TNF-alpha is a susceptibility factor for non-paraneoplastic LEMS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Disease Susceptibility / immunology
  • Female
  • Humans
  • Immunity, Innate / genetics
  • Interleukin-10 / biosynthesis*
  • Lambert-Eaton Myasthenic Syndrome / genetics
  • Lambert-Eaton Myasthenic Syndrome / immunology*
  • Male
  • Middle Aged
  • Tumor Necrosis Factor-alpha / biosynthesis*
  • Up-Regulation / genetics
  • Up-Regulation / immunology*

Substances

  • Tumor Necrosis Factor-alpha
  • Interleukin-10